Adaptation and Validation of the Diabetic Foot Ulcer Scale-Short Form in Spanish Subjects.
diabetic foot ulcer
psychometric validation
quality of life
reliability
type 2 diabetes
validity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Aug 2020
03 Aug 2020
Historique:
received:
18
06
2020
revised:
30
07
2020
accepted:
31
07
2020
entrez:
7
8
2020
pubmed:
7
8
2020
medline:
7
8
2020
Statut:
epublish
Résumé
Diabetic foot ulcer (DFU) is a chronic complication that negatively affects the quality of life (QoL) of diabetic patients. In Spain, there is no specifically designed and validated instrument to assess the QoL of patients with DFU. Our aim was to adapt the Diabetic Foot Ulcer Scale-Short Form (DFS-SF) questionnaire to a Spanish population and validate it. A prospective, observational design was used. The DFS-SF was administered by personal interview. The validated SF-36 and EQ-5D generic instruments were used as reference tools. The reliability, validity, and sensitivity to changes were assessed using standard statistical methods. A sample of 141 patients with DFU was recruited. The content validity was 3.46 on average (maximum score of 4). The internal consistency of the DFS-SF subscales showed a standardized Cronbach's α range between 0.720 and 0.948. The DFS-SF domains showed excellent reproducibility measures (intraclass correlation coefficient from 0.77-0.92). The criterion validity was good with significant correlations between each DFS-SF subscale and its corresponding SF-36 and EQ-5D subscales (
Identifiants
pubmed: 32756508
pii: jcm9082497
doi: 10.3390/jcm9082497
pmc: PMC7465700
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
ID : CB15/00071
Organisme : Ministerio de Educación, Cultura y Deporte
ID : FPU15/03005
Commentaires et corrections
Type : ErratumIn
Références
Health Qual Life Outcomes. 2014 Aug 20;12:131
pubmed: 25138117
Med Care. 2000 Sep;38(9 Suppl):II84-90
pubmed: 10982093
Health Qual Life Outcomes. 2017 Jan 21;15(1):15
pubmed: 28109278
J Diabetes Complications. 2008 Nov-Dec;22(6):400-7
pubmed: 18413188
Pharmacoeconomics. 2003;21(17):1277-90
pubmed: 14986739
Int Wound J. 2016 Oct;13(5):892-903
pubmed: 25601358
Endocrinol Diabetes Nutr. 2018 Nov;65(9):479-485
pubmed: 30108031
Diabetes Metab. 2005 Jun;31(3 Pt 1):263-71
pubmed: 16142017
Patient. 2008 Apr 1;1(2):137-45
pubmed: 22272810
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:2-6
pubmed: 26409930
J Diabetes Complications. 2000 Sep-Oct;14(5):235-41
pubmed: 11113684
Biomed Res Int. 2016;2016:7217586
pubmed: 27190996
Diabetologia. 2012 Nov;55(11):2906-12
pubmed: 22890823
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:37-44
pubmed: 26332424
Med Care. 2002 Apr;40(4 Suppl):II45-51
pubmed: 12064581
Angiology. 2017 Mar;68(3):242-250
pubmed: 27225697
Diabet Med. 2008 May;25(5):557-63
pubmed: 18346154
Semin Vasc Surg. 2015 Sep-Dec;28(3-4):165-71
pubmed: 27113283
Diabetes Care. 2018 Mar;41(3):391-397
pubmed: 29463665
Diabetologia. 2012 Mar;55(3):552-65
pubmed: 22246373
Foot Ankle Int. 2008 Nov;29(11):1074-8
pubmed: 19026199
Diabetologia. 2008 May;51(5):747-55
pubmed: 18297261
Hormones (Athens). 2016 Jul;15(3):394-403
pubmed: 27394704
J Pain. 2006 Apr;7(4):290-9
pubmed: 16618473
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:45-74
pubmed: 26386266